Quantcast
Last updated on April 17, 2014 at 15:32 EDT

Latest Myelin Stories

2011-01-26 20:35:14

New research from the University of North Carolina at Chapel Hill School of Medicine describes a key molecular mechanism in nerve fibers that ensures the rapid conductance of nervous system impulses. New research from the University of North Carolina at Chapel Hill School of Medicine describes a key molecular mechanism in nerve fibers that ensures the rapid conductance of nervous system impulses. The findings appear online Jan. 27, 2011 in the journal Neuron. Our hard-wired nerve fibers or...

41dbcee7e4f3731a10b8bb3e29e0381e
2011-01-12 12:46:42

British scientists have shown how our brain "wiring" develops in the womb and say their findings will help in the understanding of a range of brain and psychiatric disorders. Researchers from the Institute of Psychiatry at King's College London scanned babies' brains to monitor the formation of insulating layers around nerve cells. They discovered that by the age of nine months, the process was visible in all brain areas and in some regions had developed a near adult-like level. "We...

2010-12-21 00:01:51

2010: A Year of Significant Progress in MS Research (Vocus/PRWEB) December 20, 2010 Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first...

2010-12-20 05:04:00

National MS Society Leads the Way in Cutting Edge Research to Stop MS, Restore Function and End MS Forever NEW YORK, Dec. 20, 2010 /PRNewswire-USNewswire/ -- Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through...

2010-11-27 00:00:51

Mile7 recognized for creativity and excellence on the web with Silver Award for the website, WhereAreTheCures.org Portland, OR (PRWEB) November 25, 2010 Mile7, a web application development company working from Portland, Oregon, today announced that it had won a Silver Award for design and development of wherearethecures.org, created for the Myelin Repair Foundation. The website is focused on the development of a greater understanding of the barriers slowing the discovery and development...

2010-11-24 07:54:43

(Ivanhoe Newswire) -- You may not be able to teach an old dog new tricks, but you can repurpose medicine with those intentions. A drug originally developed to treat chronic pain, has proven successful in treating and reversing the effects of multiple sclerosis, or MS, as well. MS is an inflammatory disease where the body's immune system attacks a protective sheath called myelin that encompasses nerves in the spinal cord and brain. As the disease progresses, the myelin develops lesions, or...

2010-11-23 23:43:10

Researchers have found evidence that an environmental pollutant may play an important role in causing multiple sclerosis and that a hypertension drug might be used to treat the disease. The toxin acrolein was elevated by about 60 percent in the spinal cord tissues of mice with a disease similar to multiple sclerosis, said Riyi Shi, a medical doctor and a professor of neuroscience and biomedical engineering in Purdue University's Department of Basic Medical Sciences, School of Veterinary...

2010-11-18 17:01:43

Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder. Watkins and her colleagues in CU-Boulder's department of psychology and neuroscience discovered that a single injection of a compound called ATL313 -- an anti-inflammatory drug being developed to treat chronic pain -- stopped the progression of...

2010-11-17 22:20:45

By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease. A study reported November 17 online in Neuron shows that these cells, called NG2+, grow and expand rapidly during early life, eventually morphing into mature nervous system cells called oligodendrocytes. These "oligos" help speed the transmission of electrical...

2010-11-17 09:00:00

NEW YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 /PRNewswire/ -- Provid Pharmaceuticals, Inc, a drug discovery company, and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced an expansion of their partnership to support Provid's preclinical studies of their candidate MS drug, PV-267. This novel, highly selective small molecule is designed to block a critical step in the autoimmune...